Ohio Cultivator Ascension BioMedical Adds 47,000 Square Feet

Ascension BioMedical is pushing forward with a major expansion in Oberlin, Ohio, adding 47,000 square feet of cultivation space across two facilities as the state's medical cannabis market continues to mature.

The vertically integrated operator is constructing a new 28,000-square-foot building while simultaneously renovating an existing 19,000-square-foot facility. The dual-track approach suggests the company is betting on sustained demand growth in Ohio's medical program, which has seen steady patient enrollment since launching in 2019.

Ohio currently has around 33 licensed cultivators serving approximately 137,000 registered medical cannabis patients. The market generated $467 million in sales last year, though operators have faced persistent challenges with oversupply and price compression—issues that make capacity expansions a calculated risk.

The Ohio Context

Ascension's expansion comes as Ohio voters rejected adult-use legalization in 2023, keeping the state medical-only for now. That decision created uncertainty for cultivators trying to forecast long-term demand. Some operators scaled back investment plans, while others like Ascension are apparently viewing the medical market's stability as opportunity.

The Oberlin location positions Ascension in northern Ohio's Lorain County, within range of Cleveland's patient base. The company operates under Ohio's dual-license structure, which allows certain businesses to both cultivate and process cannabis products.

Industry watchers note that facility expansions typically take 12-18 months from groundbreaking to first harvest, meaning Ascension's new capacity won't hit the market until late 2025 at earliest. That timeline could work in the company's favor if patient counts continue climbing or if adult-use legislation gains traction in the statehouse.

Market Dynamics

Ohio's medical program has shown resilience despite the adult-use setback. Monthly sales have held relatively steady around $38-40 million, and the state's pharmacy count has grown to 130 locations. But wholesale prices for flower have dropped roughly 30% since 2022, squeezing cultivator margins.

The renovation component of Ascension's project suggests the company is optimizing existing infrastructure rather than abandoning it—a pragmatic move given current market conditions. Renovating 19,000 square feet is typically more cost-effective than new construction and can incorporate efficiency upgrades like LED lighting and climate control improvements.

For context, 28,000 square feet of cultivation space can yield anywhere from 1,500 to 3,000 pounds of finished flower per harvest cycle, depending on cultivation methods and plant density. With multiple harvests annually, that's substantial output entering an already competitive market.

What's Next

The expansion's success will likely hinge on whether Ohio's legislature revisits adult-use cannabis in upcoming sessions. Several lawmakers have indicated interest in crafting a legislative pathway after voters narrowly rejected the ballot measure. Adult-use would dramatically expand the addressable market but would also bring new competition.

Ascension hasn't disclosed the project's total investment or expected completion date. The company also hasn't announced whether the expansion will focus on specific product lines or cultivation techniques, though Ohio's medical program allows for various product formats including flower, concentrates, and edibles.

Ohio's medical cannabis market remains one of the more tightly regulated in the country, with strict testing requirements and product tracking. Any new capacity must navigate that regulatory framework while competing on price and quality with established operators.

This article is based on original reporting by www.cannabisbusinesstimes.com.